Merida Biosciences has emerged from Third Rock Ventures with $121 million in first-round financing for a pipeline of drugs for autoimmune diseases, headed by a Graves' disease candidate.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.